- THE MAGAZINE
- INFO FOR...
- ASI Store
- ASI Top 25
- Product & Literature Showcases
- Services Marketplace
- List Rental
- Market Research
- Custom Content & Marketing Services
- ASI Readers' Choice Awards
The transaction contracts will be finalized after a consultation process with the employees’ representatives of DSM in the Netherlands has been completed. The transaction is subject to approval from antitrust authorities. Closing is expected in early 2011.
“We look forward to welcoming DSM’s professional EPDM team, as well as its impressive assets to our core synthetic rubber activities,” said Axel C. Heitmann, CEO of LANXESS. “The transaction will also be an important step toward our goal of achieving roughly €1.4 billion (~ $1 billion) EBITDA pre-exceptionals in 2015.”
“The sale of DSM Elastomers completes our Vision 2010 strategy to become a focused life sciences and materials sciences company,” said Feike Sijbesma, CEO/chairman, DSM Managing Board.
For additional details, visit www.lanxess.com or www.dsm.com.